Director Global Market Access Oncology Early Assets/Business Development
Bristol Myers Squibb
August 13, 2026
Remote friendly (Princeton, NJ)
United States
Market Access
Summary:
The Director, Global Market Access Oncology Early Assets & Business Development will provide value, access, and pricing considerations into the product development governance process to maximize the value of the BMS oncology portfolio and life cycle management.
Responsibilities:
- Lead early market access strategy for assigned pipeline oncology compounds/indications; partner with clinical development, early commercialization, and cross-functional stakeholders; represent MAx on relevant Clinical Development Team/Global Program Team.
- Assess clinical development strategies to inform future access strategy; contribute to evidence generation plan and mitigation activities for market access and pricing opportunities/challenges.
- Provide oncology MAx input on Business Development requests (early commercialization and M&A/BD&L) to assess access and pricing; inform valuation; represent MAx on Valuation Core Team as needed.
- Lead asset projects/workstreams to evolve oncology MAx expertise and capabilities for Early Assets and BD.
- Monitor external environment and synthesize input to inform Market Access strategies; ensure access/value considerations are reflected in protocol design in collaboration with PASL, Pricing, HEOR, Medical & Local Markets.
- Partner with cross-functional Market Access teams and extended teams to position BMS products for success.
Qualifications:
- Undergraduate degree required; MBA/MPH/PharmD or relevant post-graduate degree preferred.
- 8+ years Market Access/Commercial experience with track record in global and/or US market access strategy, pricing and/or HEOR.
- Solid understanding of current/emerging oncology/hematology Market Access environment.
- Working knowledge of drug development & commercialization, HTA assessment, global reimbursement, and regulatory requirements; payer perspective in key markets.
- Scientific background (preferably oncology/hematology) supporting trial design impact on payer strategies; ability to partner with clinical development/medical affairs on endpoints and outcomes research needs.
- Ability to contribute to market access strategic scenarios; work effectively cross-functionally.
- Ability to translate scientific/clinical value into economic value.
Benefits (explicitly stated):
- Health coverage (medical, pharmacy, dental, vision), wellbeing support, financial wellbeing/protection (e.g., 401(k), disability, life insurance, etc.).
- Paid time off incl. flexible time off (US exempt), or 160 hours annual paid vacation (Phoenix/Puerto Rico/Rayzebio exempt/non-exempt/hourly), plus national holidays.
- Other time off based on eligibility (e.g., paid sick time, volunteer days, leaves of absence, Global Shutdown).
Compensation (explicitly stated):
- Princeton, NJ, US: $196,390–$237,982.
The Director, Global Market Access Oncology Early Assets & Business Development will provide value, access, and pricing considerations into the product development governance process to maximize the value of the BMS oncology portfolio and life cycle management.
Responsibilities:
- Lead early market access strategy for assigned pipeline oncology compounds/indications; partner with clinical development, early commercialization, and cross-functional stakeholders; represent MAx on relevant Clinical Development Team/Global Program Team.
- Assess clinical development strategies to inform future access strategy; contribute to evidence generation plan and mitigation activities for market access and pricing opportunities/challenges.
- Provide oncology MAx input on Business Development requests (early commercialization and M&A/BD&L) to assess access and pricing; inform valuation; represent MAx on Valuation Core Team as needed.
- Lead asset projects/workstreams to evolve oncology MAx expertise and capabilities for Early Assets and BD.
- Monitor external environment and synthesize input to inform Market Access strategies; ensure access/value considerations are reflected in protocol design in collaboration with PASL, Pricing, HEOR, Medical & Local Markets.
- Partner with cross-functional Market Access teams and extended teams to position BMS products for success.
Qualifications:
- Undergraduate degree required; MBA/MPH/PharmD or relevant post-graduate degree preferred.
- 8+ years Market Access/Commercial experience with track record in global and/or US market access strategy, pricing and/or HEOR.
- Solid understanding of current/emerging oncology/hematology Market Access environment.
- Working knowledge of drug development & commercialization, HTA assessment, global reimbursement, and regulatory requirements; payer perspective in key markets.
- Scientific background (preferably oncology/hematology) supporting trial design impact on payer strategies; ability to partner with clinical development/medical affairs on endpoints and outcomes research needs.
- Ability to contribute to market access strategic scenarios; work effectively cross-functionally.
- Ability to translate scientific/clinical value into economic value.
Benefits (explicitly stated):
- Health coverage (medical, pharmacy, dental, vision), wellbeing support, financial wellbeing/protection (e.g., 401(k), disability, life insurance, etc.).
- Paid time off incl. flexible time off (US exempt), or 160 hours annual paid vacation (Phoenix/Puerto Rico/Rayzebio exempt/non-exempt/hourly), plus national holidays.
- Other time off based on eligibility (e.g., paid sick time, volunteer days, leaves of absence, Global Shutdown).
Compensation (explicitly stated):
- Princeton, NJ, US: $196,390–$237,982.